AccuGen™ clinical common pathogenic microorganism detection uses Kangjian's independently developed multiplex PCR+NGS patented technology to perform high-throughput sequencing of common clinical pathogenic microorganisms, and compares the sequencing data with a dedicated database of pathogenic microorganisms through bioinformatics methods. , obtain suspected pathogenic microorganism species and related drug resistance information, provide rapid and accurate diagnosis basis for infected patients, and guide the rational application of drugs.

Identification of 330 pathogenic microorganisms and 150 drug resistance genes at a time.